Quantitative analysis of calcium oxalate monohydrate and dihydrate for elucidating the formation mechanism of calcium oxalate kidney stones.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 25 08 2022
accepted: 21 02 2023
entrez: 9 3 2023
pubmed: 10 3 2023
medline: 14 3 2023
Statut: epublish

Résumé

We sought to identify and quantitatively analyze calcium oxalate (CaOx) kidney stones on the order of micrometers, with a focus on the quantitative identification of calcium oxalate monohydrate (COM) and dihydrate (COD). We performed Fourier transform infrared (FTIR) spectroscopy, powder X-ray diffraction (PXRD), and microfocus X-ray computed tomography measurements (microfocus X-ray CT) and compared their results. An extended analysis of the FTIR spectrum focusing on the 780 cm-1 peak made it possible to achieve a reliable analysis of the COM/COD ratio. We succeeded in the quantitative analysis of COM/COD in 50-μm2 areas by applying microscopic FTIR for thin sections of kidney stones, and by applying microfocus X-ray CT system for bulk samples. The analysis results based on the PXRD measurements with micro-sampling, the microscopic FTIR analysis of thin sections, and the microfocus X-ray CT system observation of a bulk kidney stone sample showed roughly consistent results, indicating that all three methods can be used complementarily. This quantitative analysis method evaluates the detailed CaOx composition on the preserved stone surface and provides information on the stone formation processes. This information clarifies where and which crystal phase nucleates, how the crystals grow, and how the transition from the metastable phase to the stable phase proceeds. The phase transition affects the growth rate and hardness of kidney stones and thus provides crucial clues to the kidney stone formation process.

Identifiants

pubmed: 36893192
doi: 10.1371/journal.pone.0282743
pii: PONE-D-22-23742
pmc: PMC9997882
doi:

Substances chimiques

Calcium Oxalate 2612HC57YE

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0282743

Informations de copyright

Copyright: © 2023 Maruyama et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors declare no competing interests.

Références

Scanning Microsc. 1993 Sep;7(3):1081-104; discussion 1104-6
pubmed: 8146609
Chemistry. 2015 Dec 7;21(50):18192-201
pubmed: 26549793
Clin Chim Acta. 2000 Aug;298(1-2):1-11
pubmed: 10876000
Sci Rep. 2018 Sep 13;8(1):13731
pubmed: 30213974
J Biophotonics. 2015 Jun;8(6):457-65
pubmed: 25091212
Sci Rep. 2021 Aug 26;11(1):16841
pubmed: 34446727
Nat Rev Dis Primers. 2016 Feb 25;2:16008
pubmed: 27188687
Lancet. 1998 Jun 13;351(9118):1797-801
pubmed: 9635968
PLoS One. 2018 Aug 3;13(8):e0201460
pubmed: 30075002
ScientificWorldJournal. 2013 Nov 20;2013:423964
pubmed: 24348156
Spectrochim Acta A Mol Biomol Spectrosc. 2014 Jul 15;128:413-9
pubmed: 24682057
PLoS One. 2016 Jun 01;11(6):e0156606
pubmed: 27248840
Int Urol Nephrol. 1981;13(3):249-60
pubmed: 7327899
Anal Sci. 2015;31(9):935-42
pubmed: 26353961
Urolithiasis. 2017 Feb;45(1):19-25
pubmed: 27913855
Rev Urol. 2010 Spring;12(2-3):e86-96
pubmed: 20811557
Int J Surg. 2016 Dec;36(Pt D):624-632
pubmed: 27847293
J Pharm Sci. 1982 Sep;71(9):1059-62
pubmed: 7131277
Kidney Int. 1984 Jun;25(6):948-52
pubmed: 6471675
PLoS One. 2013 Jul 09;8(7):e68624
pubmed: 23874695
Adv Urol. 2018 Feb 4;2018:3068365
pubmed: 29515627

Auteurs

Mihoko Maruyama (M)

Graduate School of Engineering, Osaka University, Suita, Japan.
Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan.

Koichi P Sawada (KP)

Graduate School of Engineering, Osaka University, Suita, Japan.

Yutaro Tanaka (Y)

Department of Nephro-urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.

Atsushi Okada (A)

Department of Nephro-urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.

Koichi Momma (K)

National Museum of Nature and Science, Tsukuba, Japan.

Masanori Nakamura (M)

Nagoya Institute of Technology, Nagoya, Aichi, Japan.

Ryota Mori (R)

Graduate School of Engineering, Osaka University, Suita, Japan.

Yoshihiro Furukawa (Y)

Department of Earth Science, Tohoku University, Sendai, Japan.

Yuki Sugiura (Y)

Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Takamatsu, Kagawa, Japan.

Rie Tajiri (R)

Tajiri Thin Section Laboratory, Higashiosaka, Osaka, Japan.

Kazumi Taguchi (K)

Department of Nephro-urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.

Shuzo Hamamoto (S)

Department of Nephro-urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.

Ryosuke Ando (R)

Department of Nephro-urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.

Katsuo Tsukamoto (K)

Graduate School of Engineering, Osaka University, Suita, Japan.

Kazufumi Takano (K)

Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Kyoto, Japan.

Masayuki Imanishi (M)

Graduate School of Engineering, Osaka University, Suita, Japan.

Masashi Yoshimura (M)

Institute of Laser Engineering, Osaka University, Suita City, Osaka, Japan.

Takahiro Yasui (T)

Department of Nephro-urology, Nagoya City University, Graduate School of Medical Sciences, Nagoya, Japan.

Yusuke Mori (Y)

Graduate School of Engineering, Osaka University, Suita, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH